Concorde Asset Management, LLC Twist Bioscience Corp Transaction History
Concorde Asset Management, LLC
- $159 Million
- Q2 2024
A detailed history of Concorde Asset Management, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Concorde Asset Management, LLC holds 11,401 shares of TWST stock, worth $494,803. This represents 0.35% of its overall portfolio holdings.
Number of Shares
11,401
Previous 12,913
11.71%
Holding current value
$494,803
Previous $443,000
26.64%
% of portfolio
0.35%
Previous 0.3%
Shares
4 transactions
Others Institutions Holding TWST
# of Institutions
280Shares Held
66.9MCall Options Held
209KPut Options Held
111K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.13MShares$266 Million2.75% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.07MShares$263 Million0.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.59MShares$243 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$235 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.42MShares$149 Million0.04% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.45B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...